The Wall Street Journal reports that STAAR Surgical Company, a leading player in the ophthalmic surgical space and its subsidiaries, is engaged in the design, development, manufacture, marketing, and sale of implantable lenses for the eye, along with companion delivery systems for the efficient administration of these lenses. The company has established itself as a reliable provider of the Visian implantable Collamer lens product family (ICLs), which are specifically designed to cater to a wide range of visual disorders such as myopia, hyperopia, astigmatism, and presbyopia. Additionally, the company's Hyperopic ICLs have received critical acclaim for their efficacy in the treatment of far-sightedness. The product portfolio of STAAR Surgical Company also includes preloaded silicone cataract intraocular lenses, injector systems for use in cataract surgery, injector parts, and an array of other related instruments and devices. The company markets its products to healthcare providers including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. Its products are primarily used by ophthalmologists. STAAR Surgical Company has a strong presence in the United States, Japan, Canada, Germany, Spain, the United Kingdom, and Singapore. The company sells its products through its own sales representatives, independent distributors, and sales representatives in China, Korea, India, France, Benelux, Italy, and other international markets. STAAR Surgical Company, founded in 1982, is headquartered in Lake Forest, California.
STAAR Surgical Company's ticker is STAA
The company's shares trade on the NASDAQ stock exchange
They are based in Monrovia, California
There are 201-500 employees working at STAAR Surgical Company
It is staar.com/our-mission
STAAR Surgical Company is in the Services sector
STAAR Surgical Company is in the Medical Appliances & Equipment industry
The following five companies are STAAR Surgical Company's industry peers: